Insider Selling: ICU Medical, Inc. (NASDAQ:ICUI) Director Sells 972 Shares of Stock

ICU Medical, Inc. (NASDAQ:ICUI) Director David C. Greenberg sold 972 shares of the business’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $158.11, for a total value of $153,682.92. Following the sale, the director now owns 5,037 shares in the company, valued at approximately $796,400.07. This trade represents a 16.18 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

ICU Medical Trading Up 1.3 %

ICUI traded up $2.00 during trading on Wednesday, hitting $159.75. The company’s stock had a trading volume of 245,094 shares, compared to its average volume of 274,609. ICU Medical, Inc. has a twelve month low of $83.26 and a twelve month high of $196.26. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The stock’s fifty day moving average price is $175.61 and its 200-day moving average price is $146.51. The firm has a market capitalization of $3.91 billion, a P/E ratio of -34.62 and a beta of 0.66.

Hedge Funds Weigh In On ICU Medical

Institutional investors have recently added to or reduced their stakes in the business. Innealta Capital LLC acquired a new position in ICU Medical in the second quarter valued at approximately $32,000. Hexagon Capital Partners LLC raised its position in shares of ICU Medical by 162.7% during the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 122 shares during the period. Allworth Financial LP raised its position in shares of ICU Medical by 100.0% during the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 100 shares during the period. Russell Investments Group Ltd. raised its position in shares of ICU Medical by 46.4% during the first quarter. Russell Investments Group Ltd. now owns 546 shares of the medical instruments supplier’s stock worth $59,000 after purchasing an additional 173 shares during the period. Finally, Venturi Wealth Management LLC raised its position in shares of ICU Medical by 1,510.0% during the third quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock worth $59,000 after purchasing an additional 302 shares during the period. 96.10% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on ICUI shares. Jefferies Financial Group started coverage on ICU Medical in a research note on Monday, October 14th. They issued a “hold” rating and a $183.00 price objective on the stock. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. KeyCorp lifted their price objective on ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 13th. Raymond James lifted their price objective on ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research note on Thursday, September 12th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $173.00.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.